|
|
||||||||
American Journal of Clinical Nutrition, Vol 65, 1507-1511, Copyright © 1997 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
JI Wolfsdorf and JF Crigler Jr
Department of Medicine, Children's Hospital, Boston, MA 02115, USA. Wolfsdorf@A1.TCH.Harvard.Edu
The goal of treatment of type I glycogen storage disease (GSD-I) is to prevent hypoglycemia and its biochemical consequences. In seven patients with GSD-I with a mean age of 19.5 y (range: 18.8-21.7 y), we compared the biochemical effects of isoenergetic amounts of uncooked cornstarch (UCS; 1.76 +/- 0.41 g/kg) given in random order on consecutive nights either as a single dose at 2100 (time 0) or as equally divided doses at 2100 and 0200. Over the 10-h period of observation there were significant regimen-by-time interactions for plasma glucose, serum insulin, and blood lactate concentrations. Mean time-averaged plasma glucose (5.8 +/- 0.5 compared with 4.9 +/- 0.9 mmol/L) and serum insulin (244 +/- 93 compared with 151 +/- 57 pmol/L) concentrations from 0 to 360 min were significantly higher after the single dose; blood lactate and serum fatty acid concentrations were not significantly different. At 360 min, mean plasma glucose (4.8 +/- 1.2 compared with 4.7 +/- 1.6 mmol/L) and serum insulin (138 +/- 76 compared with 136 +/- 116 pmol/L) concentrations were virtually identical. After a single dose, plasma glucose concentrations were > or = 3.9 mmol/L for 7 h in five of seven subjects; three subjects were treated for hypoglycemia after 7-9.5 h. With divided doses, plasma glucose concentrations were > or = 3.9 mmol/L for 9 h in six of seven subjects; hypoglycemia occurred at 6 h in one subject. A single dose (1.76 +/- 0.41 g/kg) of UCS at bedtime maintains plasma glucose concentrations > or = 3.9 mmol/L for > or = 7 h in most young adults with GSD-I.
This article has been cited by other articles:
![]() |
C. E Correia, K. Bhattacharya, P. J Lee, J. J Shuster, D. W Theriaque, M. N Shankar, G P. A Smit, and D. A Weinstein Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib Am. J. Clinical Nutrition, November 1, 2008; 88(5): 1272 - 1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Bauer, M. R. Murphy, B. W. Wolf, and G. C. Fahey Jr Estimates of Starch Digestion in the Rat Small Intestine Differ from Those Obtained Using In Vitro Time-Sensitive Starch Fractionation Assays J. Nutr., July 1, 2003; 133(7): 2256 - 2261. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Wolf, K. A. Garleb, Y. S. Choe, P. M. Humphrey, and K. C. Maki Pullulan Is a Slowly Digested Carbohydrate in Humans J. Nutr., April 1, 2003; 133(4): 1051 - 1055. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kalergis, A. Schiffrin, R. Gougeon, P. J.H. Jones, and J.-F. Yale Impact of Bedtime Snack Composition on Prevention of Nocturnal Hypoglycemia in Adults With Type 1 Diabetes Undergoing Intensive Insulin Management Using Lispro Insulin Before Meals: A randomized, placebo-controlled, crossover trial Diabetes Care, January 1, 2003; 26(1): 9 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Wolf, P. M. Humphrey, C. W. Hadley, K. S. Maharry, K. A. Garleb, and J. L. Firkins Supplemental Fructose Attenuates Postprandial Glycemia in Zucker Fatty fa/fa Rats J. Nutr., June 1, 2002; 132(6): 1219 - 1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Axelsen, P. Lonnroth, R. A. Lenner, M.-R. Taskinen, and U. Smith Suppression of nocturnal fatty acid concentrations by bedtime carbohydrate supplement in type 2 diabetes: effects on insulin sensitivity, lipids, and glycemic control Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1108 - 1114. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |